Evidence map›Paper›PMID 36568454›Full record

ArticleIndian journal of urology : IJU : journal of the Urological Society of India

Perioperative outcomes following robot-assisted partial nephrectomy for complex renal masses: A Vattikuti Collective Quality Initiative database study.

Gopal Sharma, Milap Shah, Puneet Ahluwalia, Prokar Dasgupta, Benjamin J Challacombe, Mahendra Bhandari, Rajesh Ahlawat, Sudhir Rawal, Nicolo M Buffi, Ananthakrishnan Sivaraman and 13 more

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of urology : IJU : journal of the Urological Society of India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Author Reply Re: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  5. Re: Sharma G, Shah M, Ahluwalia P, Dasgupta P, Challacombe BJ, Bhandari M,Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 18 institutions in 9 countries.

Gopal SharmaDepartment of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
Milap ShahDepartment of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
Puneet AhluwaliaDepartment of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
Prokar DasguptaKing's Health Partners, Faculty of Life Sciences and Medicine, King's College, London, UK.
Benjamin J ChallacombeDepartment of Urology, Guy's and St. Thomas' Hospital, London, UK.
Mahendra BhandariVattikuti Foundation, Henry Ford Hospital, Detroit, MI, Washington, USA.
Rajesh AhlawatDepartment of Urology, Medanta - The Medicity Hospital, New Delhi, India.
Sudhir RawalRajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
Nicolo M BuffiDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.
Ananthakrishnan SivaramanDepartment of Urooncology, Chennai Urology and Robotics Institute, Chennai, Tamil Nadu, India.
James R PorterSwedish Medical Center, Seattle, Washington, USA.
Craig RogersDepartment of Urology, Henry Ford Hospital, Detroit, MI, Washington, USA.
Alexandre MottrieORSI Academy, Melle, Belgium, Europe.
Ronney AbazaCentral Ohio Urology Group, Mount Carmel St. Ann's Hospital, OH, USA.
Khoon Ho RhaDepartment of Urology, Yonsei University Health System, Seoul, South Korea.
Daniel MoonDepartment of Urology, Royal Melbourne Clinical School, Peter MacCallum Hospital, University of Melbourne, Melbourne, Australia.
Yuvaraja B ThyavihallyDepartment of Urooncology, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India.
Dipen J ParekhDepartment of Urology, University of Miami Health System, Miami, FL, USA.
Umberto CapitanioDepartment of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, MI, Washington, USA.
Kris K MaesCenter for Robotics and Minimally Invasive Surgery, Hospital Da Luz, Luz Sáude, Portugal.
Francesco PorpigliaDepartment of Urology, San Luigi Gonzaga Hospital of Orbassano, Turin, Italy.
Levent TurkeriDepartment of Urology, Altuzinade Hospital, Acıbadem M.A. Aydınlar University, Istanbul, Turkey.
Gagan GautamDepartment of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
Max Healthcare · INHenry Ford Hospital · USAcıbadem Adana Hospital · TRHospital da Luz · PTHumanitas University · ITIRCCS Ospedale San Raffaele · ITKing's College London · GBKokilaben Dhirubhai Ambani Hospital · INMedanta The Medicity · INMount Carmel St. Ann's · USORSI Academy · BEOspedale San Luigi Gonzaga · ITPeter MacCallum Cancer Centre · AURajiv Gandhi Cancer Institute and Research Centre · INSt Thomas' Hospital · GBSwedish Medical Center · USUniversity of Miami Health System · USYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Outcomes of robot-assisted partial nephrectomy (RAPN) depend on tumor complexity, surgeon experience and patient profile among other variables. We aimed to study the perioperative outcomes of RAPN for patients with complex renal masses using the Vattikuti Collective Quality Initiative (VCQI) database that allowed evaluation of multinational data. Methods: From the VCQI, we extracted data for all the patients who underwent RAPN with preoperative aspects and dimensions used for an anatomical (PADUA) score of ≥10. Multivariate logistic regression was conducted to ascertain predictors of trifecta (absence of complications, negative surgical margins, and warm ischemia times [WIT] <25 min or zero ischemia) outcomes. Results: Of 3,801 patients, 514 with PADUA scores ≥10 were included. The median operative time, WIT, and blood loss were 173 (range 45-546) min, 21 (range 0-55) min, and 150 (range 50-3500) ml, respectively. Intraoperative complications and blood transfusions were reported in 2.1% and 6%, respectively. In 8.8% of the patients, postoperative complications were noted, and surgical margins were positive in 10.3% of the patients. Trifecta could be achieved in 60.7% of patients. Clinical tumor size, duration of surgery, WIT, and complication rates were significantly higher in the group with a high (12 or 13) PADUA score while the trifecta was significantly lower in this group (48.4%). On multivariate analysis, surgical approach (retroperitoneal vs. transperitoneal) and high PADUA score (12/13) were identified as predictors of the trifecta outcomes. Conclusion: RAPN may be a reasonable surgical option for patients with complex renal masses with acceptable perioperative outcomes.

Identifiers

PMID36568454
PMCPMC9787447
OpenAlexW4312211268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.